Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
2nd May 201810:02 amRNSDirectorate Change
30th Apr 20184:15 pmRNSTotal Voting Rights
24th Apr 20183:45 pmRNSPublication of a Prospectus
19th Apr 201810:15 amRNSPre Stabilisation Notice
18th Apr 20184:34 pmRNSPublication of a Prospectus
13th Apr 20187:00 amRNSRestricted Tier 1 Roadshow Announcement
6th Apr 20184:00 pmRNSDirector/PDMR Shareholding
6th Apr 20184:00 pmRNSBlock listing Interim Review
29th Mar 20182:00 pmRNSTotal Voting Rights
27th Mar 20184:23 pmRNSNotice of AGM
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAnnual Financial Report
7th Mar 201810:30 amRNSDirector/PDMR Shareholding
28th Feb 201811:00 amRNSTotal Voting Rights
27th Feb 20182:30 pmRNSHolding(s) in Company
23rd Feb 20187:01 amRNSAcquisition of Standard Life Assurance
12th Feb 20189:00 amRNSHolding(s) in Company
12th Feb 20189:00 amRNSDirector/PDMR Shareholding
31st Jan 201811:45 amRNSTotal Voting Rights
30th Jan 20187:00 amRNSResidency Update
29th Dec 20171:00 pmRNSHolding(s) in Company
29th Dec 20171:00 pmRNSTotal Voting Rights
19th Dec 20175:00 pmRNSHolding(s) in Company
6th Dec 20174:30 pmRNSDirector/PDMR Shareholding
4th Dec 20174:00 pmRNSDirector Declaration
30th Nov 20174:00 pmRNSTotal Voting Rights
28th Nov 20174:30 pmRNSHolding(s) in Company
8th Nov 20175:20 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:45 pmRNSHolding(s) in Company
31st Oct 20173:00 pmRNSTotal Voting Rights
27th Oct 20174:30 pmRNSHolding(s) in Company
27th Oct 20174:30 pmRNSHolding(s) in Company
20th Oct 20174:30 pmRNSHolding(s) in Company
18th Oct 20174:45 pmRNSHolding(s) in Company
16th Oct 20174:30 pmRNSHolding(s) in Company
13th Oct 20174:15 pmRNSHolding(s) in Company
9th Oct 20174:00 pmRNSBlock listing Interim Review
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
4th Oct 20174:45 pmRNSDirector/PDMR Shareholding
29th Sep 20173:00 pmRNSTotal Voting Rights
13th Sep 20174:30 pmRNSPublication of Suppl.Prospcts
12th Sep 20179:15 amRNSHolding(s) in Company
12th Sep 20179:15 amRNSHolding(s) in Company
7th Sep 20173:30 pmRNSDirector/PDMR Shareholding
31st Aug 20174:45 pmRNSTotal Voting Rights
31st Aug 20174:45 pmRNSHolding(s) in Company
24th Aug 20177:00 amRNS2017 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.